DE60015058D1 - Kombinationsimpfstoff zur steigerung der Immunität gegen Brucellose - Google Patents

Kombinationsimpfstoff zur steigerung der Immunität gegen Brucellose

Info

Publication number
DE60015058D1
DE60015058D1 DE60015058T DE60015058T DE60015058D1 DE 60015058 D1 DE60015058 D1 DE 60015058D1 DE 60015058 T DE60015058 T DE 60015058T DE 60015058 T DE60015058 T DE 60015058T DE 60015058 D1 DE60015058 D1 DE 60015058D1
Authority
DE
Germany
Prior art keywords
ops
brucellosis
different
opss
brucella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60015058T
Other languages
English (en)
Other versions
DE60015058T2 (de
Inventor
John W Cherwonogrodzky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Minister of National Defence of Canada
UK Secretary of State for Defence
Original Assignee
Minister of National Defence of Canada
UK Secretary of State for Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minister of National Defence of Canada, UK Secretary of State for Defence filed Critical Minister of National Defence of Canada
Publication of DE60015058D1 publication Critical patent/DE60015058D1/de
Application granted granted Critical
Publication of DE60015058T2 publication Critical patent/DE60015058T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1221—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Brucella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/098—Brucella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60015058T 1999-12-15 2000-12-13 Kombinationsimpfstoff zur steigerung der Immunität gegen Brucellose Expired - Lifetime DE60015058T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17076599P 1999-12-15 1999-12-15
US170765 1999-12-15

Publications (2)

Publication Number Publication Date
DE60015058D1 true DE60015058D1 (de) 2004-11-25
DE60015058T2 DE60015058T2 (de) 2006-02-16

Family

ID=22621165

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60015058T Expired - Lifetime DE60015058T2 (de) 1999-12-15 2000-12-13 Kombinationsimpfstoff zur steigerung der Immunität gegen Brucellose

Country Status (6)

Country Link
US (1) US6582699B2 (de)
EP (1) EP1108433B1 (de)
AT (1) ATE279944T1 (de)
AU (1) AU780331B2 (de)
CA (1) CA2328321C (de)
DE (1) DE60015058T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7364745B2 (en) * 2004-02-06 2008-04-29 Virginia Tech Intellectual Properties, Inc. Development of a live, attenuated, recombinant vaccine for Brucellosis
GB0724668D0 (en) * 2007-12-19 2008-01-30 Secr Defence Vaccines for Brucellosis
RU2484481C1 (ru) * 2011-09-30 2013-06-10 Государственное научное учреждение Всероссийский научно-исследовательский институт бруцеллеза и туберкулеза животных Российской академии сельскохозяйственных наук (ГНУ ВНИИБТЖ Россельхозакадемии) Способ получения эритроцитарного антигена для реакции непрямой гемагглютинации при бруцеллезе
KR101753580B1 (ko) * 2015-08-24 2017-07-06 대한민국 브루셀라 캐니스 항원의 제조 방법
CN108359009B (zh) * 2017-12-28 2021-06-04 吉林医药学院 布鲁氏菌单链抗体及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2849632B2 (ja) * 1988-04-08 1999-01-20 社団法人北里研究所 ワクチン製剤
WO1993016728A1 (en) * 1992-02-25 1993-09-02 The Texas A & M University System Improved vaccin against brucella abortus
US5951987A (en) * 1995-08-22 1999-09-14 Her Majesty The Queen As Represented By The Minister Of National Defence Of Her Majesty'canadian Government Polysaccharide vaccine to enhance immunity against brucellosis
US6444210B1 (en) * 1996-07-03 2002-09-03 Her Majesty the Queen in right of Canada, as represented by the Minister of National Defence of Her Majesty′s Canadian Goverment Bacterial and synthetic polysaccharide immunomodulators that enhance general immunity

Also Published As

Publication number Publication date
CA2328321C (en) 2011-02-08
EP1108433B1 (de) 2004-10-20
DE60015058T2 (de) 2006-02-16
ATE279944T1 (de) 2004-11-15
AU780331B2 (en) 2005-03-17
CA2328321A1 (en) 2001-06-15
US6582699B2 (en) 2003-06-24
AU7230900A (en) 2001-06-21
EP1108433A2 (de) 2001-06-20
US20020122808A1 (en) 2002-09-05
EP1108433A3 (de) 2003-06-25

Similar Documents

Publication Publication Date Title
BRPI9912663B8 (pt) vacina contra cáncer e polipeptìdeo.
BR9906927A (pt) Proteìnas de neisseria meningitidis
DE60310562D1 (de) Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
ES2180651T3 (es) Vacuna que contiene acidos nucleicos.
PT1542732E (pt) Proteínas de fusão de mycobacterium tuberculosis
WO2001064920A3 (en) Hybrid expression of neisserial proteins
ATE378403T1 (de) Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern
ATE454163T1 (de) Bakterielle impfstoffe, enthaltend auxotrophe attenuierte listerienstämme, welche heterologe antigene exprimieren
ITFI920052A1 (it) Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.
WO2003070187A3 (en) Fusion proteins of mycobacterium tuberculosis
FR2741806B1 (fr) Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline
FR21C1005I2 (fr) Antigenes de streptococcus pyogenes et fragments d'adn correspondants
DK0909323T3 (da) Helicobacter pylori-bakterioferritin
DE69419966D1 (de) Impstoff gegen Streptococcus suis-Infektion
ATE259879T1 (de) Für menschliches papillomavirus stamm 18 kodierende dns
DE60015058D1 (de) Kombinationsimpfstoff zur steigerung der Immunität gegen Brucellose
WO1999004011A3 (en) Hiv-1 group o antigens and uses thereof
DE60124526D1 (de) Methode zur identifizierung von helicobacter antigenen
ATE346931T1 (de) Clostridium perfringens impfstoff
SE9602822D0 (sv) New receptor
DK1416956T3 (da) Autologe T-celle-vaccinematerialer samt fremgangsmåde til deres fremstilling
DE69402201D1 (de) Phosphorhaltiges, metallurgisches silizium zur herstellung von organohalosilanen
MY137258A (en) Bacterial insecticidal protein
WO2002077648A3 (en) Pathogenic and commensal vaccine antigens
DE69119785D1 (de) Zweiphasensystem zur herstellung und präsentation von fremdantigenen in hybriden lebendimpfstoffen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition